326 related articles for article (PubMed ID: 33673205)
1. Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence.
Villas-Boas GR; Lavorato SN; Paes MM; de Carvalho PMG; Rescia VC; Cunha MS; de Magalhães-Filho MF; Ponsoni LF; de Carvalho AAV; de Lacerda RB; da S Leite L; da S Tavares-Henriques M; Lopes LAF; Oliveira LGR; Silva-Filho SE; da Silveira APS; Cuman RKN; de S Silva-Comar FM; Comar JF; do A Brasileiro L; Dos Santos JN; de Freitas WR; Leão KV; da Silva JG; Klein RC; Klein MHF; da S Ramos BH; Fernandes CKC; de L Ribas DG; Oesterreich SA
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33673205
[TBL] [Abstract][Full Text] [Related]
2. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.
Barrett JE; Vanover KE
Psychopharmacology (Berl); 1993; 112(1):1-12. PubMed ID: 7870996
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders.
Dawson LA; Bromidge SM
Curr Top Med Chem; 2008; 8(12):1008-23. PubMed ID: 18691129
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
5. 5-hydroxytryptamine (5-HT) receptor ligands.
Kitson SL
Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
Alex KD; Pehek EA
Pharmacol Ther; 2007 Feb; 113(2):296-320. PubMed ID: 17049611
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Serotonin in Neuropsychiatric Disorders.
Pourhamzeh M; Moravej FG; Arabi M; Shahriari E; Mehrabi S; Ward R; Ahadi R; Joghataei MT
Cell Mol Neurobiol; 2022 Aug; 42(6):1671-1692. PubMed ID: 33651238
[TBL] [Abstract][Full Text] [Related]
10. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
Montgomery SA; Fineberg N
Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
[TBL] [Abstract][Full Text] [Related]
11. Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review.
Gusev E; Sarapultsev A
Curr Pharm Des; 2024; 30(3):180-214. PubMed ID: 38151838
[TBL] [Abstract][Full Text] [Related]
12. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
13. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety.
File SE; Kenny PJ; Cheeta S
Pharmacol Biochem Behav; 2000 May; 66(1):65-72. PubMed ID: 10837844
[TBL] [Abstract][Full Text] [Related]
14. The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy.
Moret C; Briley M
Eur J Pharmacol; 2000 Sep; 404(1-2):1-12. PubMed ID: 10980257
[TBL] [Abstract][Full Text] [Related]
15. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
Keck BJ; Lakoski JM
Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic modulation of synapses in the developing gerbil lateral superior olive.
Fitzgerald KK; Sanes DH
J Neurophysiol; 1999 Jun; 81(6):2743-52. PubMed ID: 10368394
[TBL] [Abstract][Full Text] [Related]
17. Serotonin (5-HT) and migraine.
Silberstein SD
Headache; 1994; 34(7):408-17. PubMed ID: 7928325
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine aspects of the serotonergic hypothesis of depression.
Van de Kar LD
Neurosci Biobehav Rev; 1989; 13(4):237-46. PubMed ID: 2691929
[TBL] [Abstract][Full Text] [Related]
19. Serotonin receptors in brain revisited.
Palacios JM
Brain Res; 2016 Aug; 1645():46-9. PubMed ID: 26740406
[TBL] [Abstract][Full Text] [Related]
20. The role of serotonin in depression and anxiety.
Baldwin D; Rudge S
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():41-5. PubMed ID: 7622823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
